ENO2 and non-small cell lung carcinoma: In addition, this is the first study to compare the diagnostic value of TrxR activity with multiple NSCLC biomarkers, including NSE, CA19-9, CEA, and Cyfra21-1, and report the sensitivity and specificity of TrxR in combination with other NSCLCs biomarkers, which was distinct from the previous studies.